PTC Therapeutics, Inc.PTC Therapeutics, Inc.PTC Therapeutics, Inc.

PTC Therapeutics, Inc.

No trades
See on Supercharts

Price target

39.710.000.00%
The 14 analysts offering 1 year price forecasts for PTCT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 15 analysts giving stock ratings to PTCT in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


PTCT EPS for the last quarter is −1.29 USD despite the estimation of −1.12 USD. In the next quarter EPS is expected to reach −1.51 USD. Track more of PTC Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter PTC Therapeutics, Inc. revenue is expected to reach ‪172.01 M‬ USD. Check out PTC Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, PTCT price target is 39.71 USD with a max estimate of 64.00 USD and a min estimate of 26.00 USD. Check if this forecast comes true in a year, meanwhile watch PTC Therapeutics, Inc. stock price chart and keep track of the current situation with PTCT news and stock market news.
We've gathered opinions of 15 analysts rating PTCT stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.